Íris Pétursdóttir

Screening for Monoclonal Gammopathy of Undetermined Significance: A Population-Based Randomized Clinical Trial. First Results from the Iceland Screens, Treats, or Prevents Multiple Myeloma (iStopMM) Study

I. Olafsson, P. T. Onundarson, B. Agnarsson, 2021, Blood.

Prevalence of Smoldering Multiple Myeloma: Results from the Iceland Screens, Treats, or Prevents Multiple Myeloma (iStopMM) Study

I. Olafsson, P. T. Onundarson, B. Agnarsson, 2021, Blood.

Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies

G. T. Gunnarsson, Andri S. Björnsson, I. Olafsson, 2021, Blood Cancer Journal.